Sana Biotechnology (SANA) director Hans Bishop receives 6,297 vested RSU shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Sana Biotechnology director Hans Edgar Bishop reported an equity award. He received 6,297 shares of Common Stock as a grant with a price per share of $0.00, consisting of fully vested restricted stock units. After this compensation-related acquisition, his directly held stake increased to 5,854,800 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Bishop Hans Edgar
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 6,297 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 5,854,800 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Shares granted: 6,297 shares
Grant price per share: $0.00 per share
Total shares after transaction: 5,854,800 shares
3 metrics
Shares granted
6,297 shares
Common Stock grant reported on Form 4
Grant price per share
$0.00 per share
Stated price for awarded Common Stock
Total shares after transaction
5,854,800 shares
Direct holdings following the award
Key Terms
restricted stock units, Common Stock, Form 4
3 terms
restricted stock units financial
"Consists of fully vested restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Common Stock financial
"security_title: "Common Stock" in the reported transaction"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"INSIDER FILING DATA (Form 4) for Sana Biotechnology, Inc."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
What did Sana Biotechnology (SANA) director Hans Edgar Bishop report on this Form 4?
Hans Edgar Bishop reported receiving 6,297 Sana Biotechnology Common Stock shares as a grant. The award was a compensation-related acquisition, not an open-market purchase, and was reported as fully vested restricted stock units at a stated price of $0.00 per share.
Was Hans Edgar Bishop’s Sana (SANA) transaction a stock purchase or a grant?
The transaction was a stock grant, not an open-market purchase. It is coded as an award acquisition, with 6,297 Common Stock shares received at $0.00 per share, representing fully vested restricted stock units granted as part of compensation.
Does the Sana Biotechnology (SANA) Form 4 show any insider stock sales?
The Form 4 does not show any insider sales. It reports only one transaction, an acquisition via a stock grant of 6,297 Common Stock shares, coded as a grant or award, with no disposition or sale transactions listed in the summary.
What are the fully vested restricted stock units mentioned in the SANA Form 4 footnote?
The filing states the 6,297 granted shares consist of fully vested restricted stock units. This means the units have already vested and converted into Common Stock, giving Bishop direct ownership of the corresponding shares without further vesting conditions.